Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism
Authors:
- Ioana ZosinIZIoana Zosin
- Christiane Maser-GluthCMChristiane Maser-Gluth
- Derik HermsenDHDerik Hermsen
- Kenko CupistiKCKenko Cupisti
- Matthias SchottMSMatthias Schott
- Sven SchinnerSSSven Schinner
- Wolfram T KnoefelWKWolfram T Knoefel
- Werner A ScherbaumWSWerner A Scherbaum
- Holger S WillenbergHWHolger S Willenberg
- 3 June 2010
- journal article
- Published by Springer Nature in Hypertension Research
- Vol. 33 (8) , 850-856
Abstract
It is suggested to use the aldosterone-to-renin ratio (ARR) as a first test in the screening for primary aldosteronism (PA). However, many groups rather rely on the determination of urinary tetrahydroaldosterone secretion; others calculate a ratio of urinary aldosterone to plasma renin activity. The aim of the present study was to evaluate the usefulness of different parameters of aldosterone excess in the case finding of PA. The study included 28 patients with PA and 33 subjects with essential hypertension. Clinical data, which included the hormonal parameters, serum aldosterone, plasma renin concentration, urinary free aldosterone and metabolites and serum and urinary electrolyte levels were analyzed. These indices of aldosterone excess, the ARR, serum sodium to urinary sodium to (serum potassium)(2) to urinary potassium (SUSPPUP) ratio and combinations of these parameters were compared between the groups. Receiver-operating curve analysis revealed that the ARR multiplied by the SUSPPUP ratio (ARR x SUSPPUP) is the most reliable screening test, with a sensitivity of 92.3% and a specificity of 93.9% (cutoff point 199.2 (mmol l(-1))(-1)). The combination of ARR x SUSPPUP ratio with urinary free aldosterone divided by the plasma renin concentration rendered a specificity of 100%. Less useful was the correction of urinary free aldosterone and its metabolites for sodium excretion. Although the ARR and urinary free aldosterone divided by renin are good tests in the screening for PA, the combination of ARR with SUSPPUP ratio is a better indicator of an aldosterone excess and aldosterone action in patients with ongoing antihypertensive medication. Antihypertensive drugs only marginally interfere with the SUSPPUP ratio, but they may influence the ARR, whereby the effects in PA patients seem to be negligible.Keywords
This publication has 36 references indexed in Scilit:
- Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate MeasurementClinical Chemistry, 2009
- The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronismEuropean Journal of Clinical Investigation, 2008
- Aldosterone, but not Increased Na+Influx or NF-κB Activation, Increases Kidney-specific WNK1 Gene Expression in Renal Collecting Duct CellsHormone and Metabolic Research, 2008
- New Mechanisms to Control Aldosterone SynthesisHormone and Metabolic Research, 2008
- The Cutoff Value of Aldosterone-to-Renin Ratio for the Diagnosis of Primary Aldosteronism in Patients Taking Antihypertensive MedicineClinical and Experimental Hypertension, 2008
- Moderate Weight Loss Reduces Renin and Aldosterone but does not Influence Basal or Stimulated Pituitary-adrenal Axis FunctionHormone and Metabolic Research, 2007
- Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolitesEuropean Journal of Endocrinology, 2006
- Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertensionJournal of Human Hypertension, 2006
- Screening for Primary Aldosteronism in Essential Hypertension: Diagnostic Accuracy of the Ratio of Plasma Aldosterone Concentration to Plasma Renin ActivityClinical Chemistry, 2005
- Primary AldosteronismAnnals of the New York Academy of Sciences, 2002